Publications

Detailed Information

Lupus Erythematosus Panniculitis: Clinicopathological, Immunophenotypic, and Molecular Studies

DC Field Value Language
dc.contributor.authorPark, Hyun Sun-
dc.contributor.authorChoi, Jung Won-
dc.contributor.authorKim, Byoung-kwon-
dc.contributor.authorCho, Kwang Hyun-
dc.date.accessioned2012-07-04T01:22:30Z-
dc.date.available2012-07-04T01:22:30Z-
dc.date.issued2010-02-
dc.identifier.citationAMERICAN JOURNAL OF DERMATOPATHOLOGY; Vol.32 1; 24-30ko_KR
dc.identifier.issn0193-1091-
dc.identifier.urihttps://hdl.handle.net/10371/78360-
dc.description.abstractLupus erythematosus panniculitis (LEP) is an inflammatory disorder of the subcutaneous fat in patients with lupus erythematosus (LE). It is a rare variant of the disease, which occurs approximately in 1%-3% of patients with cutaneous LE. The purpose of this study was to investigate the clinical, histopathologic, immunophenotypical, and molecular profiles of LEP. We performed a retrospective study of 19 biopsy specimens from 17 patients with LEP. We reviewed their clinical data and reexamined the histopathology. Immunophenotyping and molecular studies were done using sections from paraffin-embedded formalin-fixed tissue. The most common clinical manifestation was a depressed patch on upper arm. Patients showed good response to variable treatment modalities, but, generally, relapse of panniculitis was noted when treatment was discontinued. Histopathologically, most specimens revealed lymphoplasmacytic lobular panniculitis with epidermal and dermal changes of LE, hyaline fat necrosis, and lymphoid follicles. Immunohistochemistry showed a mixture of T and B cells in dermis and subcutis with a slight preponderance of T cell. Although the polymerase chain reaction analysis of the T-cell receptor-gamma gene rearrangement showed a polyclonal smear in 89.5% of cases, a small portion of specimens demonstrated monoclonality. LEP is a chronic recurrent disease with characteristic features. Its diagnosis is often challenging, and a precise diagnosis is achievable only upon elaborate clinicopathologic correlation and integrated interpretation of all diagnostic criteria.ko_KR
dc.language.isoenko_KR
dc.publisherLIPPINCOTT WILLIAMS & WILKINSko_KR
dc.subjectlupus erythematosus panniculitisko_KR
dc.subjectlupus profundusko_KR
dc.titleLupus Erythematosus Panniculitis: Clinicopathological, Immunophenotypic, and Molecular Studiesko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor박현선-
dc.contributor.AlternativeAuthor김병권-
dc.contributor.AlternativeAuthor조광현-
dc.contributor.AlternativeAuthor최정원-
dc.identifier.doi10.1097/DAD.0b013e3181b4a5ec-
dc.citation.journaltitleAMERICAN JOURNAL OF DERMATOPATHOLOGY-
dc.description.citedreferenceAguilera P, 2007, J AM ACAD DERMATOL, V56, P643, DOI 10.1016/j.jaad.2006.08.029-
dc.description.citedreferenceSmedby KE, 2006, CANCER EPIDEM BIOMAR, V15, P2069, DOI 10.1158/1055-9965.EPI-06-0300-
dc.description.citedreferenceJacyk WK, 2006, INT J DERMATOL, V45, P717-
dc.description.citedreferenceMassone C, 2005, J CUTAN PATHOL, V32, P396-
dc.description.citedreferenceAckerman AB, 2005, J CUTAN PATHOL, V32, P254-
dc.description.citedreferenceMassone C, 2004, AM J SURG PATHOL, V28, P719-
dc.description.citedreferenceMagro CM, 2004, J CUTAN PATHOL, V31, P300-
dc.description.citedreferenceCassis TB, 2004, J AM ACAD DERMATOL, V50, P465, DOI 10.1016/S0190-9622(03)02784-1-
dc.description.citedreferenceHoque SR, 2003, BRIT J DERMATOL, V148, P516-
dc.description.citedreferenceNg PPL, 2002, INT J DERMATOL, V41, P488-
dc.description.citedreferencePICHARDO RO, 2002, AM J DERMATOPATH, V24, P507-
dc.description.citedreferenceRequena L, 2001, J AM ACAD DERMATOL, V45, P325, DOI 10.1061/mjd.2001.114735-
dc.description.citedreferenceMagro CM, 2001, J CUTAN PATHOL, V28, P235-
dc.description.citedreferenceREQUENA L, 2001, J AM ACAD DERMATOL, V45, P362-
dc.description.citedreferenceTheriault C, 2000, MODERN PATHOL, V13, P1269-
dc.description.citedreferenceSignoretti S, 1999, AM J PATHOL, V154, P67-
dc.description.citedreferenceMartens PB, 1999, J RHEUMATOL, V26, P68-
dc.description.citedreferenceCho KH, 1996, INT J DERMATOL, V35, P802-
dc.description.citedreferencedeArgila D, 1996, INT J DERMATOL, V35, P680-
dc.description.citedreferenceWatanabe T, 1996, BRIT J DERMATOL, V134, P123-
dc.description.citedreferenceCAPRONI M, 1995, INT J DERMATOL, V34, P357-
dc.description.citedreferenceGONZALEZ CL, 1991, AM J SURG PATHOL, V15, P17-
dc.description.citedreferencePETERS MS, 1989, MED CLIN N AM, V73, P1113-
dc.description.citedreferenceMOSCONA R, 1986, J AM ACAD DERMATOL, V14, P840-
dc.description.citedreferenceWINKELMANN RK, 1983, ARCH DERMATOL, V119, P336-
dc.description.citedreferenceTAN EM, 1982, ARTHRITIS RHEUM, V25, P1271-
dc.description.citedreferenceSANCHEZ NP, 1981, J AM ACAD DERMATOL, V5, P673-
dc.description.citedreferenceHARRIS RB, 1979, ARCH DERMATOL, V115, P442-
dc.description.citedreferenceDIAZJOUANEN E, 1975, ANN INTERN MED, V82, P376-
dc.description.citedreferenceFLEISCHM.R, 1972, ARCH DERMATOL, V106, P509-
dc.description.citedreferenceTUFFANEL.DL, 1971, ARCH DERMATOL, V103, P231-
dc.description.citedreferenceFOUNTAIN RB, 1968, BRIT J DERMATOL, V80, P571-
dc.description.tc2-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share